Clinical trials in developing countries HAI Europe Open Seminar 21 November 2008 Annelies den Boer.

14
Clinical trials in developing countries HAI Europe Open Seminar 21 November 2008 Annelies den Boer

Transcript of Clinical trials in developing countries HAI Europe Open Seminar 21 November 2008 Annelies den Boer.

Page 1: Clinical trials in developing countries HAI Europe Open Seminar 21 November 2008 Annelies den Boer.

Clinical trials in developing countries

HAI Europe Open Seminar21 November 2008

Annelies den Boer

Page 2: Clinical trials in developing countries HAI Europe Open Seminar 21 November 2008 Annelies den Boer.

Ski where the snow is!

Page 3: Clinical trials in developing countries HAI Europe Open Seminar 21 November 2008 Annelies den Boer.

Discover Russia for conducting clinical research!

Page 4: Clinical trials in developing countries HAI Europe Open Seminar 21 November 2008 Annelies den Boer.

Billion dollar clinical research opportunity lies in India!

Page 5: Clinical trials in developing countries HAI Europe Open Seminar 21 November 2008 Annelies den Boer.
Page 6: Clinical trials in developing countries HAI Europe Open Seminar 21 November 2008 Annelies den Boer.

Dr. Amar Jessani

Many doctors in India involved in clinical trials are given enormous sums of money for recruiting patients. This leads to a conflict of interests, of which the patients are the victims. When they find they need medical attention, the financial obstacles they encounter tempt them to close their eyes to the possible risks of clinical trials.’

Page 7: Clinical trials in developing countries HAI Europe Open Seminar 21 November 2008 Annelies den Boer.

• Tests increasingly carried out in low income countries

• Popular destinations; Eastern Europe, Asia and Latin America

• Often medicines destined for consumption in lucrative Western Markets

Page 8: Clinical trials in developing countries HAI Europe Open Seminar 21 November 2008 Annelies den Boer.

Cheap

Fast

Easy

Page 9: Clinical trials in developing countries HAI Europe Open Seminar 21 November 2008 Annelies den Boer.

Scale of CT outside US/ W.Europe

No universal registration system

Scientists: 30 - 40 %

Big pharma: 30 - 70%

NGO’s: more CRO’s

Estimate SOMO: 18.000- 24.000 CTs

Page 10: Clinical trials in developing countries HAI Europe Open Seminar 21 November 2008 Annelies den Boer.

Why be concerned?

No access

Conflicts of interest

Insufficient supervision

Page 11: Clinical trials in developing countries HAI Europe Open Seminar 21 November 2008 Annelies den Boer.

Protection of participants

Declaration of Helsinki

Violations by Pfizer, Occam, Astra Zeneca

Page 12: Clinical trials in developing countries HAI Europe Open Seminar 21 November 2008 Annelies den Boer.

What to do?

CT Watch

Lobby against market authorisation in EU

Capacity building

Compulsory and public registration

Page 13: Clinical trials in developing countries HAI Europe Open Seminar 21 November 2008 Annelies den Boer.

European bottlenecks

Lack of implementation of EU directives

Medicines agencies: ‘It is not in our system’

Page 14: Clinical trials in developing countries HAI Europe Open Seminar 21 November 2008 Annelies den Boer.

Change?

13 MEP’s support position Wemos

Dutch MP’s questioned Minister

New study and call for ethical trials